USA Equities Corp
QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medi… Read more
USA Equities Corp (USAQ) - Net Assets
Latest net assets as of September 2025: $-610.91K USD
Based on the latest financial reports, USA Equities Corp (USAQ) has net assets worth $-610.91K USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.73 Million) and total liabilities ($2.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-610.91K |
| % of Total Assets | -35.22% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 221.89 |
USA Equities Corp - Net Assets Trend (2000–2024)
This chart illustrates how USA Equities Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for USA Equities Corp (2000–2024)
The table below shows the annual net assets of USA Equities Corp from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-607.76K | -61.80% |
| 2023-12-31 | $-375.62K | -592.64% |
| 2022-12-31 | $76.25K | -90.75% |
| 2021-12-31 | $824.07K | +235.46% |
| 2020-12-31 | $-608.33K | -41.54% |
| 2019-12-31 | $-429.79K | +19.44% |
| 2018-12-31 | $-533.51K | -7.81% |
| 2017-12-31 | $-494.88K | -2.35% |
| 2016-12-31 | $-483.53K | -5.05% |
| 2015-12-31 | $-460.28K | -15.18% |
| 2012-12-31 | $-399.61K | -116.12% |
| 2001-12-31 | $2.48 Million | -44.17% |
| 2000-12-31 | $4.44 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to USA Equities Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 433135000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $3.72 Million | % |
| Total Equity | $-607.76K | 100.00% |
USA Equities Corp Competitors by Market Cap
The table below lists competitors of USA Equities Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Atacama Resources International Inc
PINK:ACRL
|
$1.37 Million |
|
Novra Technologies Inc
OTCQB:NVRVF
|
$1.37 Million |
|
Hawkmoon Resources Corp
PINK:HWKRF
|
$1.37 Million |
|
CDA S.A. ZY -10
F:6LC
|
$1.37 Million |
|
Odyssey Resources Limited
V:ODX-H
|
$1.37 Million |
|
OPS Retail S.p.A.
F:DMM
|
$1.37 Million |
|
BioSenic S.A.
BR:BIOS
|
$1.37 Million |
|
Orian Sh.M. Ltd
TA:ORIN
|
$1.37 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in USA Equities Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -375,617 to -607,756, a change of -232,139.
- Net loss of 259,239 reduced equity.
- Other factors increased equity by 27,100.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-259.24K | -42.66% |
| Other Changes | $27.10K | +4.46% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares USA Equities Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $0.00 | $0.20 | x |
| 2016-12-31 | $0.00 | $0.20 | x |
| 2017-12-31 | $-0.14 | $0.20 | x |
| 2018-12-31 | $-0.15 | $0.20 | x |
| 2019-12-31 | $-0.07 | $0.20 | x |
| 2020-12-31 | $-0.09 | $0.20 | x |
| 2021-12-31 | $0.09 | $0.20 | x |
| 2022-12-31 | $0.01 | $0.20 | x |
| 2023-12-31 | $-0.04 | $0.20 | x |
| 2024-12-31 | $-0.06 | $0.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently USA Equities Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -12.16%
- • Asset Turnover: 1.18x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-107.68%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-51.91K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-32.60K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $841.60 |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-676.09K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $25.10K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $38.13K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $14.72K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-123.54K |
| 2020 | 0.00% | -262.89% | 0.42x | 0.00x | $-266.56K |
| 2021 | -93.46% | -54.45% | 0.64x | 2.68x | $-852.58K |
| 2022 | -1306.32% | -80.12% | 0.64x | 25.67x | $-1.00 Million |
| 2023 | 0.00% | -33.24% | 0.84x | 0.00x | $-430.80K |
| 2024 | 0.00% | -12.16% | 1.18x | 0.00x | $-198.46K |
Industry Comparison
This section compares USA Equities Corp's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| USA Equities Corp (USAQ) | $-610.91K | 0.00% | N/A | $1.37 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |